Polyarteritis nodosa: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "Cr " to "creatinine ") |
|||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Necrotizing vasculitis of small- and medium-sized blood vessels | *Necrotizing [[vasculitis]] of small- and medium-sized blood vessels | ||
*Skin, musculoskeletal, CNS, and GI tract (spares lung) | *Skin, musculoskeletal, CNS, and GI tract (spares lung) | ||
*Predilection to arterial bifurcations and branch sites | *Predilection to arterial bifurcations and branch sites | ||
*Microaneurysm, thrombosis, emboli, | *Microaneurysm, [[thromboembolism|thrombosis, emboli]], organ ischemia, and infarction | ||
*Etiology: Idiopathic, HBV, HCV, hairy cell leukemia | *Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]] | ||
{{Primary Vasculitis DDX}} | |||
*Cutaneous lesion + adult onset hypertension | ==Clinical Features== | ||
[[File:PMC3505767 ad-24-383-g005.png|thumb|Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.]] | |||
*Cutaneous [[rash|lesion]] + adult onset [[hypertension]] | |||
*Men > women (2:1) | *Men > women (2:1) | ||
*Peak age 40-60s | *Peak age 40-60s | ||
*Systemic: Fatigue, weight loss, weakness, fever, arthralgia | *Systemic: Fatigue, weight loss, weakness, [[fever]], [[arthralgia]] | ||
*Cutaneous lesions (1/3 patients) | *Cutaneous lesions (1/3 patients) | ||
**Tender erythematous nodules | **Tender erythematous nodules | ||
**Palpable | **Palpable [[purpura]] (fingers, ankles, malleoli, pretibial) | ||
**Digital cyanosis | **Digital cyanosis | ||
**Splinter hemorrhages | **Splinter hemorrhages | ||
**Livedo reticularis | **Livedo reticularis | ||
*Renovascular arteritis → hypertension | *Renovascular arteritis → [[hypertension]] | ||
*Peripheral neuropathies (mononeuritis multiplex, polyneuropathy) | *Peripheral neuropathies (mononeuritis multiplex, polyneuropathy) | ||
*Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation) | *Mesenteric vasculitis (abdominal angina, [[mesenteric ischemia|ischemia]], infarction, perforation) | ||
*Myocardial ischemia and heart failure | *[[Myocardial ischemia]] and [[heart failure]] | ||
*Myalgia (elevated CK) | *[[Myalgia]] (elevated CK) | ||
== | ==Differential Diagnosis== | ||
* | *Embolism, thrombosis, atherosclerosis | ||
*[[HIV]], [[Hepatitis]], IE, [[mycotic aneurysm]] | |||
*Fibromuscular dysplasia | |||
* | *Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis | ||
* | |||
* | |||
==Workup== | ==Evaluation== | ||
===Workup=== | |||
*Definitive: Tissue biopsy | *Definitive: Tissue biopsy | ||
*Labs: | *Labs: | ||
**Cr, CK, | **Cr, CK, [[LFTs]] (elevated) | ||
**CBC (Leukocytosis, normochromic anemia, thrombocytosis) | **CBC ([[Leukocytosis]], normochromic [[anemia]], [[thrombocytosis]]) | ||
**Hepatitis serology | **[[viral hepatitis|Hepatitis serology]] | ||
** | **[[Urinalysis]] ([[proteinuria]]) | ||
**ESR/CRP | **ESR/CRP | ||
*Imaging | *Imaging | ||
| Line 49: | Line 45: | ||
**Arteriograms | **Arteriograms | ||
**CT/MRI | **CT/MRI | ||
* | *Consider: [[CXR]], blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases | ||
== | ===Diagnosis=== | ||
* | ====American College of Rheumatology Criteria==== | ||
*[[ | ''Need at least 3/10 (82% sensitivity and 87% specificity)'' | ||
* | *Unexplained weight loss greater than 4kg | ||
* | *Livedo reticularis | ||
*[[Testicular Pain]] or tenderness | |||
*Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy | |||
*Mononeuropathy or polyneuropathy | |||
*New-onset diastolic blood pressure > 90mmHg | |||
*Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L) | |||
*Evidence of HBV infection (serology) | |||
*Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes | |||
*Biopsy of small- or medium-sized artery containing polymorphonuclear cells | |||
==Management== | ==Management== | ||
*Rheumatology consult | *Rheumatology consult | ||
*May warrant surgical intervention if abdominal involvement | *May warrant surgical intervention if abdominal involvement | ||
* | *[[Corticosteroids]]: | ||
**[[Prednisone]] 1mg/kg | **[[Prednisone]] 1mg/kg | ||
**[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening | **[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening | ||
*Immunosuppressive agent for moderate to severe | *Immunosuppressive agent for moderate to severe | ||
**Cyclophosphamide (600mg/m2<sup>) q2weeks x 3 doses | **[[Cyclophosphamide]] (600mg/m2<sup>) q2weeks x 3 doses | ||
*ACEI or ARB for hypertension | *[[ACEI]] or [[ARB]] for hypertension | ||
==References== | ==References== | ||
| Line 75: | Line 79: | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Vascular]] | |||
Latest revision as of 17:35, 2 August 2023
Background
- Necrotizing vasculitis of small- and medium-sized blood vessels
- Skin, musculoskeletal, CNS, and GI tract (spares lung)
- Predilection to arterial bifurcations and branch sites
- Microaneurysm, thrombosis, emboli, organ ischemia, and infarction
- Etiology: Idiopathic, HBV, HCV, hairy cell leukemia
Vasculitis Syndrome Types
- Large vessel
- Takayasu arteritis
- Giant cell arteritis (temporal arteritis)
- Medium-vessel
- Kawasaki disease
- Polyarteritis nodosa
- Thromboangiitis obliterans (Buerger's disease)
- Primary angiitis of the central nervous system
- Small-vessel
- Henoch-Schönlein purpura
- ANCA-associated vasculitides
- Granulomatosis with polyangiitis (Wegner's)
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
- Microscopic polyangiitis
- Cutaneous leukocytoclastic angiitis (“hypersensitivity vasculitis”)
- Essential cryoglobulinemia, cryoglobulinemic vasculitis due to hepatitis C
- Behçet's disease]
- Secondary vasculitides and other/miscellaneous
- Drug-induced vasculitis
- Serum sickness
- Vasculitis associated with other rheumatic diseases (e.g. SLE)
Clinical Features
- Cutaneous lesion + adult onset hypertension
- Men > women (2:1)
- Peak age 40-60s
- Systemic: Fatigue, weight loss, weakness, fever, arthralgia
- Cutaneous lesions (1/3 patients)
- Tender erythematous nodules
- Palpable purpura (fingers, ankles, malleoli, pretibial)
- Digital cyanosis
- Splinter hemorrhages
- Livedo reticularis
- Renovascular arteritis → hypertension
- Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
- Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
- Myocardial ischemia and heart failure
- Myalgia (elevated CK)
Differential Diagnosis
- Embolism, thrombosis, atherosclerosis
- HIV, Hepatitis, IE, mycotic aneurysm
- Fibromuscular dysplasia
- Microscopic polyangiitis, Granulomatosis with polyangiitis (Wegener's), Eosinophilic granulomatosis with polyangiitis (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, connective tissue disease, SLE, cryoglobulinemic vasculitis
Evaluation
Workup
- Definitive: Tissue biopsy
- Labs:
- Cr, CK, LFTs (elevated)
- CBC (Leukocytosis, normochromic anemia, thrombocytosis)
- Hepatitis serology
- Urinalysis (proteinuria)
- ESR/CRP
- Imaging
- Angiography preferred: aneurysm or stenosis of medium-sized vessels
- Arteriograms
- CT/MRI
- Consider: CXR, blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases
Diagnosis
American College of Rheumatology Criteria
Need at least 3/10 (82% sensitivity and 87% specificity)
- Unexplained weight loss greater than 4kg
- Livedo reticularis
- Testicular Pain or tenderness
- Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
- Mononeuropathy or polyneuropathy
- New-onset diastolic blood pressure > 90mmHg
- Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
- Evidence of HBV infection (serology)
- Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
- Biopsy of small- or medium-sized artery containing polymorphonuclear cells
Management
- Rheumatology consult
- May warrant surgical intervention if abdominal involvement
- Corticosteroids:
- Prednisone 1mg/kg
- Methylprednisolone (7-15mg/kg, max 1000mg IV) for severe, organ threatening
- Immunosuppressive agent for moderate to severe
- Cyclophosphamide (600mg/m2) q2weeks x 3 doses
- ACEI or ARB for hypertension
References
- Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
- Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
- Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
- Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.
